中文At the 2025 GBC Global Biomanufacturing Conference on May 9, BioGeometry earned spots on both the “Top 10 Biomanufacturing Potential Unicorns” and “Top 10 Biomanufacturing Platform Services” lists, recognized for its cutting-edge generative AI protein design technology and platform services. This dual awards underscores its role as critical infrastructure powering life-molecule innovation and the global biomanufacturing revolution.
2025 GBC Global Biomanufacturing Conference
GeoFlow V2: The First Versatile Engine for Life-Molecule Design
Launched on April 16, GeoFlow V2 is the world’s first unified atomic diffusion model for protein design. Unlike most existing models that either predict or generate, GeoFlow unifies protein structure prediction and de novo design in a single architecture, delivering end-to-end protein engineering at atomic precision.
With multi-modal capabilities, GeoFlow V2 supports to generate complex structures based on proteins, small molecules, and DNA/RNA. It transcends traditional “predictor” or “generator” tools, acting as a free protein design engine.
Applications span antibody drug development, protein engineering, and enzyme optimization. One top pharma firm used it to solubilize multi-pass transmembrane proteins while retaining structural integrity. For “undruggable” targets like HER2, it designed full-size/nanobodies with sub-nanomolar affinity and precise epitope binding, some validated in vivo.
GeoFlow V2 integrates with high-throughput wet lab of BioGeometry, enabling closed-loop design-build-test-learn cycles. This system delivers candidate molecules in 1 week and optimized solutions in 4–6 weeks, maximizing R&D efficiency.
Open Access: Shaping the Future of Protein Design
GeoFlow V2 is now offered via limited-time free trial (https://prot.design) to researchers and biotech innovators. BioGeometry invites collaboration to advance programmable, scalable future biomanufacturing.